Pharmaceuticals

Metabolically-fit Immunotherapies Portfolio

Pancratistatin Cyclic Phosphate Prodrugs and Phenpanstatin Cyclic Phosphate Prodrugs

Cyclodepsipeptide compounds presenting anti-cancer and anti-infective activity, and their synthesis

Carbohydrate-Mediated Tumor Targeting

Compounds to Modulate Retinoid X Receptors

Methods and Compositions Related to Glycoprotein-Immunoglobulin Fusions

Bi-specific Antibodies as a Therapeutic for Alzheimer’s Disease

Reducing Oxidative Stress with Multifunctional Radical Quenchers

QSOX1 as an anti-neoplastic drug target

Auristatin Tyramine Phosphate Prodrugs and Aminoquinoline Derivatives